Dr Michel Komajda is a Cardiologist at the National Academy of Medicine in Paris, France. He is a past president of the European Society of Cardiology and the French Cardiac Society. He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE, and PARAGON. He has also published over 250 articles in peer-reviewed journals.
Dr Michel Komajda is a member of the editorial board for the Journal of Asian Pacific Society of Cardiology, published by Radcliffe Cardiology on behalf of the Asian Pacific Society of Cardiology.
